Global Roundtable (GRCU) Stock Price, News & Analysis

Company Overview

Global Roundtable Corporation operates in the health and wellness business. It also provides products and ancillary services in the mental wellness segment and optical-vision medical care. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0003
• Volume: 5.12 million shs
• Average Volume: 8.45 million shs
• Market Capitalization: $1.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GRCU Stock Analysis - Frequently Asked Questions

How have GRCU shares performed this year?

Global Roundtable's stock was trading at $0.0001 on January 1st, 2024. Since then, GRCU stock has increased by 100.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here.

How do I buy shares of Global Roundtable?

Shares of GRCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Global Roundtable own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Roundtable investors own include Labor Smart (LTNC), Acrivon Therapeutics (ACRV), Processa Pharmaceuticals (PCSA), Aurora Innovation (AUR), NVIDIA (NVDA), Pfizer (PFE) and American Cannabis (AMMJ).

Company Calendar

• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Transportation services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GRCU
• CUSIP: N/A
• CIK: N/A
• Web: greencurescorp.com
• Phone: (844) 420-4728
• Fax: 415-339-4609
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,093,420,000
• Free Float: N/A
• Market Cap: $1.22 million
• Optionable: Not Optionable
• Beta: 1.17